Amanta Healthcare promoter sells shares worth Rs 7.86 lakh

1 min read     Updated on 18 Jun 2026, 02:44 AM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

Amanta Healthcare Limited disclosed that promoter group member Kirit Ambalal Desai sold 5,000 equity shares for Rs 7.86 lakh on the NSE on June 15, 2026. The sale reduced his holding from 2.92% to 2.91%. The company confirmed no derivatives trading occurred and filed the disclosure under SEBI PIT Regulations.

powered bylight_fuzz_icon
43232297

*this image is generated using AI for illustrative purposes only.

Amanta Healthcare Limited disclosed that Kirit Ambalal Desai, a member of its promoter group, sold 5,000 equity shares through an open market transaction on June 15, 2026. The sale reduced his shareholding in the company to 2.91%, a move that was formally intimated to the management on June 17, 2026. This transaction was executed on the National Stock Exchange (NSE) and is part of the regulatory disclosures required under the SEBI (Prohibition of Insider Trading) Regulations, 2015.

The shares were sold at a total value of Rs 7,86,550. Prior to this disposal, Desai held 11,33,079 equity shares, which accounted for 2.92% of the company's paid-up share capital. Following the transaction, his holding has adjusted to 11,28,079 equity shares. The company confirmed that no trading activity was reported in the derivatives segment by the promoter group member during this period.

Transaction Details

The disclosure was submitted in Form C to the stock exchanges, outlining the specifics of the acquisition and disposal of securities. The transaction was classified as a market sale, and the value provided excludes taxes, brokerage, and other associated charges.

Parameter Details
Name of the shareholder Kirit Ambalal Desai
Category Member of Promoter Group
Securities sold Equity Shares
Number of shares sold 5,000
Transaction value Rs 7,86,550
Date of sale June 15, 2026
Date of intimation June 17, 2026
Mode of disposal Market Sale
Exchange NSE

Holding Pattern

The table below details the change in the promoter group member's shareholding before and after the transaction.

Holding Stage Number of Shares Percentage of Shareholding
Prior to disposal 11,33,079 2.92%
Post disposal 11,28,079 2.91%

The company stated that the disclosure was made in compliance with Regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015. The filing was signed by Nikhita Dinodia, Company Secretary & Compliance Officer of Amanta Healthcare Limited.

Historical Stock Returns for Amanta Healthcare

1 Day5 Days1 Month6 Months1 Year5 Years
+4.99%+5.23%+24.30%+43.49%+10.33%+10.33%

Does this sale signal a potential trend of further divestment by other members of the promoter group?

How might the market interpret this reduction in promoter holding regarding the company's future growth prospects?

Are there any upcoming corporate events, such as lock-in period expirations, that could trigger additional selling pressure?

Amanta Healthcare commissions 10.8 MWp solar plant for captive use

1 min read     Updated on 31 May 2026, 02:31 AM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

Amanta Healthcare commissioned a 10.8 MWp solar power plant at Village Baroda, Taluka Matar, District Kheda, on May 30, 2026. The plant will supply electricity for captive consumption at the company's Hariyala factory, aiming to reduce operational costs and enhance sustainability. The intimation was submitted under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

powered bylight_fuzz_icon
41707529

*this image is generated using AI for illustrative purposes only.

Amanta Healthcare has successfully commissioned a 10.8 MWp solar power plant at Village Baroda, Taluka Matar, District Kheda, to generate electricity for its captive consumption. The generation of units from the solar power plant commenced on May 30, 2026. This strategic move is expected to reduce the company's operational costs and enhance overall sustainability by utilizing green energy for its manufacturing needs.

The company received all requisite approvals prior to the commencement of operations. The power generated will be utilized entirely for captive consumption, directly supporting Amanta Healthcare's production facilities. This development aligns with the company's objectives to optimize energy expenses and strengthen its environmental footprint.

Project Details

The solar power plant is located in Gujarat and has a capacity of 10.8 MWp. The facility is designed to meet the energy requirements of the company's factory located at Hariyala on National Highway No. 8.

Parameter Details
Location Village Baroda, Taluka Matar, District Kheda
Capacity 10.8 MWp
Purpose Captive Consumption
Commencement Date May 30, 2026

The intimation regarding the commissioning was made to the stock exchanges under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Historical Stock Returns for Amanta Healthcare

1 Day5 Days1 Month6 Months1 Year5 Years
+4.99%+5.23%+24.30%+43.49%+10.33%+10.33%

What is the projected percentage reduction in Amanta Healthcare's operational costs following the commissioning of the solar plant?

Does Amanta Healthcare have plans to expand its renewable energy capacity to other manufacturing facilities?

How will the shift to green energy impact the company's ESG ratings and attractiveness to sustainability-focused investors?

More News on Amanta Healthcare

1 Year Returns:+10.33%